Toothaker R D, Welling P G
Annu Rev Pharmacol Toxicol. 1980;20:173-99. doi: 10.1146/annurev.pa.20.040180.001133.
The recent literature concerning interactions between ingested food and orally administered drugs, and the resulting effects on the rate and extent of drug absorption, has been reviewed. As was observed previously (1, 2) food has been shown to have a variable effect on drug absorption, and the observed changes are not entirely predictable from a mechanistic viewpoint. While drug-food interactions are shown to give rise to a variety of effects, the majority of reported interactions give rise to either reduced or delayed drug profiles in the circulation. With some drugs such as nitrofurantoin, doxycycline, and lithium, the presence of food increases clinical efficacy by reducing the incidence of local GI side effects. While there appear to be no reports of increases or decreases in the actual therapeutic efficacy of drugs due to food, the frequency of food related changes in drug bioavailability, and the magnitude of some of the effects, suggests that observed changes in drug absorption are likely to have profound clinical consequences particularly with drugs that have low therapeutic indices, steep dose-response curves, or clearly defined therapeutic or toxic levels in the body. The review provides further evidence of the need for greater control in the relationship between drug administration and food ingestion.
近期有关摄入食物与口服药物之间的相互作用及其对药物吸收速率和程度的影响的文献已被综述。正如之前所观察到的(1, 2),食物已被证明对药物吸收有可变的影响,并且从机制角度来看,所观察到的变化并不完全可预测。虽然药物 - 食物相互作用显示会产生多种影响,但大多数报道的相互作用会导致循环中药物分布减少或延迟。对于某些药物,如呋喃妥因、多西环素和锂,食物的存在通过降低局部胃肠道副作用的发生率来提高临床疗效。虽然似乎没有关于食物导致药物实际治疗效果增加或减少的报道,但与食物相关的药物生物利用度变化的频率以及某些影响的程度表明,所观察到的药物吸收变化可能具有深远的临床后果,特别是对于治疗指数低、剂量 - 反应曲线陡峭或体内有明确治疗或毒性水平的药物。该综述进一步证明了在药物给药与食物摄入之间的关系中需要加强控制。